The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology

DSpace/Manakin Repository

The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology

Citable link to this page

 

 
Title: The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology
Author: Loupy, A.; Haas, M.; Solez, K.; Racusen, L.; Glotz, D.; Seron, D.; Nankivell, B. J.; Colvin, R. B.; Afrouzian, M.; Akalin, E.; Alachkar, N.; Bagnasco, S.; Becker, J. U.; Cornell, L.; Drachenberg, C.; Dragun, D.; de Kort, H.; Gibson, I. W.; Kraus, E. S.; Lefaucheur, C.; Legendre, C.; Liapis, H.; Muthukumar, T.; Nickeleit, V.; Orandi, B.; Park, W.; Rabant, M.; Randhawa, P.; Reed, E. F.; Roufosse, C.; Seshan, S. V.; Sis, B.; Singh, H. K.; Schinstock, C.; Tambur, A.; Zeevi, A.; Mengel, M.

Note: Order does not necessarily reflect citation order of authors.

Citation: Loupy, A., M. Haas, K. Solez, L. Racusen, D. Glotz, D. Seron, B. J. Nankivell, et al. 2016. “The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.” American Journal of Transplantation 17 (1): 28-41. doi:10.1111/ajt.14107. http://dx.doi.org/10.1111/ajt.14107.
Full Text & Related Files:
Abstract: The XIII Banff meeting, held in conjunction the Canadian Society of Transplantation in Vancouver, Canada, reviewed the clinical impact of updates of C4d‐negative antibody‐mediated rejection (ABMR) from the 2013 meeting, reports from active Banff Working Groups, the relationships of donor‐specific antibody tests (anti‐HLA and non‐HLA) with transplant histopathology, and questions of molecular transplant diagnostics. The use of transcriptome gene sets, their resultant diagnostic classifiers, or common key genes to supplement the diagnosis and classification of rejection requires further consensus agreement and validation in biopsies. Newly introduced concepts include the i‐IFTA score, comprising inflammation within areas of fibrosis and atrophy and acceptance of transplant arteriolopathy within the descriptions of chronic active T cell–mediated rejection (TCMR) or chronic ABMR. The pattern of mixed TCMR and ABMR was increasingly recognized. This report also includes improved definitions of TCMR and ABMR in pancreas transplants with specification of vascular lesions and prospects for defining a vascularized composite allograft rejection classification. The goal of the Banff process is ongoing integration of advances in histologic, serologic, and molecular diagnostic techniques to produce a consensus‐based reporting system that offers precise composite scores, accurate routine diagnostics, and applicability to next‐generation clinical trials.
Published Version: doi:10.1111/ajt.14107
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363228/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:32630488
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters